GlassScriptPhysician profile
Saba Ahmed
NPI 1548765506
$2,470.44
in general payments reported to CMS, 2019-2025
33 companies · $1,012 in 2025
The $1,012 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $204 · 2024: $1,254 · 2025: $1,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,470.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $240.97 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Xeris Pharmaceuticals, INC. | $239.00 | 2024-2025 | Recorlev, Gvoke Hypopen |
| Lilly USA, LLC | $234.77 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Corcept Therapeutics | $161.27 | 2024-2025 | Korlym |
| Medtronic, INC. | $159.04 | 2023-2025 | Minimed 780g |
| Dexcom, INC. | $158.80 | 2023-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $154.31 | 2024-2025 | |
| Cequr Corporation | $131.57 | 2024-2025 | Cequr Simplicity |
| Alexion Pharmaceuticals, INC. | $95.55 | 2023-2025 | Strensiq |
| Insulet Corporation | $86.70 | 2024 | Omnipod |
| Abbott Laboratories | $75.08 | 2024-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Actelion Pharmaceuticals US, INC. | $74.04 | 2024-2025 | Opsumit, Opsynvi, Uptravi |
| Takeda Pharmaceuticals U.S.A., INC. | $73.66 | 2025 | Hyqvia |
| Amgen INC. | $57.16 | 2024-2025 | Evenity, Prolia |
| Radius Health, INC. | $56.54 | 2024-2025 | Tymlos |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $51.24 | 2024-2025 | Unithroid |
| Kyowa Kirin, INC. | $41.66 | 2023-2025 | Crysvita |
| Novartis Pharmaceuticals Corporation | $35.29 | 2024 | |
| Recordati_rare_diseases_inc. | $33.05 | 2024 | Signifor Lar, Isturisa |
| Averitas Pharma INC. | $29.94 | 2024 | Qutenza |
| Axsome Therapeutics, INC. | $29.40 | 2025 | Sunosi |
| Tandem Diabetes Care, INC. | $28.66 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $28.11 | 2025 | |
| Embecta Corp. | $26.94 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Pfizer INC. | $23.92 | 2025 | |
| Lundbeck LLC | $23.20 | 2025 | Vyepti |
| Inspire Medical Systems, INC. | $21.46 | 2025 | Inspire |
| Daiichi Sankyo INC. | $20.37 | 2025 | Injectafer |
| Eisai INC. | $19.50 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $18.67 | 2025 | |
| Sequel Med Tech, LLC | $16.85 | 2025 | Twiist |
| Vanda Pharmaceuticals INC. | $14.09 | 2025 | Ponvory |
| Aucta Pharmaceuticals, INC. | $9.63 | 2024 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saba Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.